Clinical Application of Novel Therapies for Coronary Angiogenesis: Overview, Challenges, and Prospects

Area of Science:

• Cardiovascular research
• Vascular biology
• Regenerative medicine

Background:

• Cardiovascular diseases, particularly ischemic heart disease, are leading global causes of death.
• Current treatments fail to fully address advanced heart failure.
• Preclinical successes in revascularization therapies have not translated effectively to clinical practice.

Purpose of the Study:

• To review the structure, vascularization, and regulation of the vascular system, focusing on the endothelium.
• To discuss preclinical and clinical findings in therapeutic angiogenesis.
• To identify challenges and future prospects in the field of therapeutic angiogenesis for heart failure.

Main Methods:

• Review of existing literature on vascular biology and therapeutic angiogenesis.
• Analysis of preclinical and clinical study outcomes.
• Discussion of challenges including patient selection, endpoint measurement, comorbidities, and delivery systems.

Main Results:

• The endothelium plays a critical role in vascular health and disease.
• Therapeutic angiogenesis strategies face significant hurdles in clinical translation.
• Novel bioengineering approaches are emerging to enhance delivery and efficacy.

Conclusions:

• Despite challenges, therapeutic angiogenesis is an evolving field with potential for heart failure treatment.
• Optimizing delivery systems and patient selection are crucial for future success.
• Continued research into bioengineering and vascular biology is essential for advancing therapeutic angiogenesis.